News
To find out more about how the tariffs will impact K-Beauty in the U.S., I spoke to Cho on her unique perspective as both a K ...
Discover insights from Karyopharm's Q1 2025 earnings call, highlighting selinexor's $1B potential, SENTRY trial updates, and strategies to overcome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results